Contact Information:

Media Contact

Joseph Caputo
jcaputo@cell.com
617-397-2802

Twitter: CellPressNews

http://www.cellpress.com




Kredyty mieszkaniowe Kredyty mieszkaniowe

Sprawdź aktualny ranking najlepszych kredytów mieszkaniowych w Polsce - atrakcyjne kredytowanie nieruchomości.

PRESS-NEWS.org - Press Release Distribution
FREE PRESS RELEASES DISTRIBUTION
RSS - Press News Release
Add Press Release

Melatonin explains the mystery of seasonal multiple sclerosis flare-ups


2015-09-10
(Press-News.org) Seasonal flare-ups in patients with multiple sclerosis are caused by plummeting levels of melatonin in the spring and summer, according to research published September 10 in Cell. The study reveals that relapses in patients with this autoimmune disorder are much less frequent in the fall and winter, when levels of the so-called darkness hormone are at their highest, but the reverse is true in the spring and summer seasons.

Moreover, treatment with melatonin improved clinical symptoms in a mouse model of multiple sclerosis by restoring a healthy balance of immune cells called T lymphocytes. The findings, which resulted from a collaboration between American and Argentinian scientists, could potentially lead to the development of novel treatments for a broad range of autoimmune disorders.

"Our work may provide an answer for the seasonal paradox by identifying melatonin, whose levels are regulated by seasonal fluctuations in day length, as an additional regulator of the immune response in multiple sclerosis," says study author Francisco J. Quintanta of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital and Harvard Medical School. "The implication is that molecules activating melatonin signaling may represent new targets for therapeutic immunomodulation in multiple sclerosis and potentially other inflammatory diseases."

Multiple sclerosis is a nervous system disorder thought to be triggered by T cells that destroy the myelin sheath--the material that surrounds and protects nerve cells. This damage slows down or blocks messages between the brain and the body, leading to symptoms such as visual disturbances, muscle weakness, trouble with coordination and balance, and thinking and memory problems. In addition to genetic factors, the disease is influenced by environmental factors such as infections, sodium intake, smoking, and vitamin D levels.

In particular, vitamin D has been considered as a factor that could potentially contribute to the seasonal flare-ups that have been observed in patients with multiple sclerosis for decades. Not only does the vitamin affect immune responses, but its synthesis is triggered by sun exposure and exhibits large seasonal fluctuations. However, these observations pose a paradox: vitamin D is expected to reduce the frequency of relapses in the spring and summer due to its anti-inflammatory effects, but that's exactly when clinical symptoms are at their worst.

To solve this seasonal paradox, Quintana and study authors Mauricio Farez and Jorge Correale of the Raúl Carrea Institute for Neurological Research (FLENI) in Argentina set out to identify additional environmental factors that could play a role. They quickly zeroed in on melatonin because levels of the hormone, which regulates circadian rhythms and immune responses, fluctuate with the seasons.

In support of this idea, the researchers discovered a negative relationship between melatonin levels and clinical relapses in 139 patients with multiple sclerosis. Because melatonin production is stimulated by darkness, levels of the hormone peaked in the fall and winter. Meanwhile, there was a 32% reduction in the number of relapses in the fall and winter compared to the spring and summer. The findings demonstrate that higher melatonin levels in the darker months are associated with an improvement in clinical symptoms.

To test if melatonin plays a causal role in relapses, the researchers gave daily injections of the hormone to mice with an autoimmune disease that recapitulates key features of multiple sclerosis. Not only did melatonin treatment improve clinical symptoms, it also restored a healthy balance of T cells in the brain, spinal cord, and several immune organs. The hormone reduced levels of harmful T cells called Th17 cells, which are known to play a major role in the development of multiple sclerosis. At the same time, melatonin treatment stimulated an increase in regulatory T cells, which keep Th17 activity in check.

"The main strength of the study is that we demonstrate with great detail the mechanisms used by melatonin to modulate the immune system. In addition to this, we show the effects of melatonin in an animal model of multiple sclerosis, human cells and patients, connecting basic research with clinical work," Farez says. "Nonetheless, our work is entirely based in patients from one particular setting and location--Buenos Aires, Argentina--and further work in other centers and with larger cohorts should be done to confirm and extend our findings in other regions with genetically distinct populations."

Because melatonin exerted its effects on T cells by activating pathways previously implicated in inflammatory bowel disease and autoimmune colitis, the same mechanisms may play a role in a broad range of autoimmune disorders. Moreover, seasonal flare-ups have also been observed in patients with lupus and rheumatoid arthritis, hinting at broader possible implications of the study. "Several melatonin-derived drugs have been used or tested in humans for other conditions such as insomnia," Farez says. "These drugs could potentially be repurposed to modulate inflammation in multiple sclerosis and other inflammatory conditions."

The researchers are currently working on a pilot clinical trial to study the effect of targeting melatonin signaling in patients with multiple sclerosis. They are also investigating additional mechanisms of action and examining whether low melatonin levels increase the risk of developing the disease. Although the findings provide strong basic and epidemiological evidence for the role of melatonin in the seasonality of multiple sclerosis flare-ups, the interplay between melatonin and other well-recognized seasonal factors such as vitamin D remains to be seen.

"In the future, melatonin or its derivatives may be used in patients with multiple sclerosis after appropriate clinical trials are conducted," Quintana says. "However, extreme caution should be exercised because our data do not show that melatonin or its analogs are effective in treating multiple sclerosis. Until a clinical trial is conducted and an appropriate drug and dosage is established, it is not recommended to use melatonin for the treatment of multiple sclerosis."

INFORMATION:

This study was supported by the Allende Foundation, the Multiple Sclerosis International Federation, Biogen Idec, Novartis Argentina, Merck Serono Argentina, the National Institutes of Health, the National Multiple Sclerosis Society, and the International Progressive MS Alliance.

Cell, Farez et al.: "Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses" http://dx.doi.org/10.1016/j.cell.2015.08.025

Cell, the flagship journal of Cell Press, is a bimonthly journal that publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. For more information, please visit http://www.cell.com/cell. To receive media alerts for Cell or other Cell Press journals, contact press@cell.com.


ELSE PRESS RELEASES FROM THIS DATE:

GI side effects of chemotherapy reduced in mice by targeting gut microbes

GI side effects of chemotherapy reduced in mice by targeting gut microbes
2015-09-10
The blame for some of chemotherapy's awful side effects may lie with our gut microbes, early evidence suggests. As chemotherapy drugs are eliminated from the body, bacteria in the gastrointestinal tract can latch onto them and transform them into toxic species that cause severe diarrhea. In a Chemistry & Biology article published online on September 10, researchers present ways to shut down the ability of GI microbes to convert chemotherapy drugs to a toxic species in mice as a first step to helping cancer patients. "The GI microbiota are the great crowd-sourcers of chemistry, ...

When it comes to touch, to give is to receive

2015-09-10
Have you ever touched someone else and wondered why his or her skin felt so incredibly soft? Well, now researchers reporting in the Cell Press journal Current Biology on September 10 present evidence that this experience may often be an illusion. In a series of studies led by Aikaterini Fotopoulou of the University College London, participants consistently rated the skin of another person as being softer than their own, whether or not it really was softer. The researchers suggest that this phenomenon may exist to ensure that humans are motivated to build social bonds ...

You'd have to be smart to walk this lazy... and people are

Youd have to be smart to walk this lazy... and people are
2015-09-10
Those of you who spend hours at the gym with the aim of burning as many calories as possible may be disappointed to learn that all the while your nervous system is subconsciously working against you. Researchers reporting in the Cell Press journal Current Biology on September 10 have found that our nervous systems are remarkably adept in changing the way we move so as to expend the least amount of energy possible. In other words, humans are wired for laziness. The findings, which were made by studying the energetic costs of walking, likely apply to most of our movements, ...

Melatonin and multiple sclerosis: Why MS symptoms may improve as the days get shorter

2015-09-10
For patients and clinicians alike, it's long been a mystery: why do symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer? A group led by Francisco Quintana, PhD, at the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital (BWH) and collaborators have found an explanation that could lead to a deeper understanding of the disease and more targeted treatment options for patients. By first looking broadly at possible environmental factors and then deeply at preclinical models of MS, the research team found that melatonin ...

Stanford scientists home in on origin of human, chimpanzee facial differences

2015-09-10
The face of a chimpanzee is decidedly different from that of a human, despite the fact that the apes are our nearest relative in the primate tree. Now researchers at the Stanford University School of Medicine have begun to pinpoint how those structural differences could arise in two species with nearly identical genetic backgrounds. The key lies in how genes involved in facial development and human facial diversity are regulated -- how much, when and where the genes are expressed-- rather than dissimilarities among the genes themselves. In particular, the researchers ...

Vision testing an effective tool for detecting concussion on the sidelines

2015-09-10
NEW YORK, NY - A timed vision test that involves rapidly reading numbers off of cards can be a valuable sideline tool for detecting whether a concussion occurred while playing sports, according to a meta-analysis and systematic review led by NYU Langone Medical Center concussion specialists. Researchers at the NYU Langone Concussion Center reviewed studies that involved athletes who sustained a concussion during sporting activities and found the vision test, known as the King-Devick test, was 86 percent sensitive in detecting whether a concussion had occurred, as confirmed ...

Solving a genetic mystery: Bridging diagnostic discovery through social media

2015-09-10
HOUSTON -- (Sept. 10, 2015) - "Help us find others like Tess." Bo Bigelow's plea jumps off the page of his blog, echoing across the continent from his leafy green home city of Portland, Maine. When he posted his call to action, all he knew was that his young daughter has a mutation in her USP7 gene and that she has global developmental delay, hip dysplasia and visual impairment caused by her brain (not a problem in her eyes themselves) among other health issues. An article in the New Yorker magazine by Seth Mnookin gave him hope that finding other children with the same ...

Pancreatic cancer stem cells could be 'suffocated' by an anti-diabetic drug

2015-09-10
Cancer cells commonly rely on glycolysis, the type of metabolism that does not use oxygen to generate their energy however, researchers from Queen Mary University of London's Barts Cancer Institute and the Spanish National Cancer Research Centre (CNIO) in Madrid have now found that not all cancer cells are alike when it comes to metabolism. PancSCs can make use of a more efficient form of metabolism, called oxidative phosphorylation or OXPHOS, which does use oxygen. OXPHOS uses a part of the cell called mitochondria and it is this which can be targeted with anti-diabetic ...

Discovery offers hope for treating leukemia relapse post-transplant

2015-09-10
Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers. There is currently no effective treatment for this stage of leukemia, and patients have only a 5 percent chance of survival over five years. AML is a fast-moving cancer of the blood and bone marrow. In patients with AML, the bone marrow produces abnormal white or red blood cells or platelets. Powerful rounds of chemotherapy can damage bone marrow, so many patients are given ...

Researchers find neuroanatomical signature for schizophrenia

2015-09-10
While it is known that the incidence and outward symptoms of schizophrenia are strongly influenced by ethnic factors--for instance, patients from Asian ethnicities are more likely to experience visual hallucinations, whereas patients from western cultures and Caucasian ethnicities are more likely to suffer from auditory hallucinations--it was unclear if brain deficits would differ amongst suffers from various ethnic backgrounds. Previous research had indicated that there were neuroanatomical signatures for schizophrenia, but a study titled, "A Neuroanatomical Signature ...

LAST 30 PRESS RELEASES:

How your brain decides blame and punishment -- and how it can be changed

Uniquely human brain region enables punishment decisions

Pinpointing punishment

Chapman University publishes research on attractiveness and mating

E-cigarettes: Special issue from Nicotine & Tobacco Research

Placental problems in early pregnancy associated with 5-fold increased risk of OB & fetal disorders

UT study: Invasive brood parasites a threat to native bird species

Criminals acquire guns through social connections

Restoring ocean health

Report: Cancer remains leading cause of death in US Hispanics

Twin study suggests genetic factors contribute to insomnia in adults

To be fragrant or not: Why do some male hairstreak butterflies lack scent organs?

International team discovers natural defense against HIV

Bolivian biodiversity observatory takes its first steps

Choice of college major influences lifetime earnings more than simply getting a degree

Dominant strain of drug-resistant MRSA decreases in hospitals, but persists in community

Synthetic biology needs robust safety mechanisms before real world application

US defense agencies increase investment in federal synthetic biology research

Robots help to map England's only deep-water Marine Conservation Zone

Mayo researchers identify protein -- may predict who will respond to PD-1 immunotherapy for melanoma

How much water do US fracking operations really use?

New approach to mammograms could improve reliability

The influence of citizen science grows despite some resistance

Unlocking secrets of how fossils form

What happens on the molecular level when smog gets into the lungs?

Using ultrasound to clean medical instruments

Platinum and iron oxide working together get the job done

Tiny silica particles could be used to repair damaged teeth, research shows

A quantum lab for everyone

No way? Charity's logo may influence perception of food in package

[Press-News.org] Melatonin explains the mystery of seasonal multiple sclerosis flare-ups
Press-News.org is a service of DragonFly Company. All Rights Reserved.
Issuers of news releases are solely responsible for the accuracy of their content.